|
業務類別
|
Biotechnology |
|
業務概覽
|
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others. |
| 公司地址
| 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432 |
| 電話號碼
| +1 858 964-3720 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.inmunebio.com |
| 員工數量
| 22 |
| Mr. David J. Moss |
Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary |
美元 405.27K |
21/04/2025 |
| Dr. Raymond J. Tesi, M.D. |
Director, President and Chief Executive Officer |
美元 513.64K |
21/04/2025 |
| Dr. Mark Lowdell, PhD |
Chief Scientific Officer |
-- |
21/04/2025 |
|
|
| Ms. Marcia Allen |
Independent Director |
21/04/2025 |
| Dr. Raymond J. Tesi, M.D. |
Director, President and Chief Executive Officer |
21/04/2025 |
| Mr. J. Kelly Ganjei |
Independent Director |
21/04/2025 |
| Mr. Timothy (Tim) Schroeder |
Independent Director |
21/04/2025 |
| Mr. Scott Juda, J.D. |
Independent Director |
21/04/2025 |
|
|
|
|
